Torrent Pharma's Q2FY24 Financial Performance Review
In this financial performance review, we delve into the results of Torrent Pharma for the second quarter of fiscal year 2024 and analyze key metrics, including revenue, expenses, net profit, and margin.
| Particulars | Q2FY23 | (Y-o-Y) % change | Q1FY24 | (Q-o-Q) % change | Q2FY24 |
| Total Income (₹crs.) | 2307 | 16.43 | 2625 | 2.32 | 2686 |
| Expenses (₹crs.) | 1844 | 15.35 | 2094 | 1.58 | 2127 |
| Net Profit (₹crs.) | 312 | 23.72 | 378 | 2.12 | 386 |
| Margin (%) | 13.52 | 0.85 | 14.40 | -0.03 | 14.37 |
REVENUE: The company reported a total income of ₹2,686 crores for Q2FY24, with a moderate 2.32% increase compared to the preceding quarter and a significant increase of 16.43% year-on-year.
EXPENSES: They also recorded expenses amounting to ₹2,127 crores in Q2FY24, with a slight 1.58% increase compared to the previous quarter year. Furthermore, expenses showed an increase of 15.35% from Q2FY23.
NET PROFIT: The net profit of the Company for Q2FY24 was ₹386 crores, reflecting a 2.12% increase compared to the preceding quarter. However, there is a significant rise of 23.72% when compared to Q2 of the previous year.
MARGINS: Torrent Pharma's margin in Q2FY24 was 14.37%. This figure showed a slight decrease of -0.03% compared to the previous quarter when the margin was 14.40%. Year-on-year, the margin exhibited a small increase, with a 0.85% change compared to Q2FY23.
In conclusion, Torrent Pharma's financial performance in Q2FY24 reflects stable revenue, a modest increase in net profit, and consistent margins and further analysis will be essential to understand the sustainability of these stable trends.
Stay tuned for more detailed updates on Torrent Pharma's financial performance in the coming quarters.